IFNB1 and multiple sclerosis: Multiple sclerosis is an autoimmune disease with incidence of genetically prone patients potentially influenced by environmental pathogens.1 The US Food and Drug Administration organization approves 8 species of drugs to reduce its symptoms, among which 4 contain interferon-beta (IFN-β).